Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium

2010105 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Investigational New Drugs

Volume 30, Issue 1, pp. 382-386

Field-Weighted Citation Impact: 4.54